New OTC drugs and devices 2001: a selective review

To create a heightened awareness of two important issues that arose over the past year with respect to over-the-counter (OTC) drugs-the possible switching of nonsedating second-generation antihistamines to OTC status and the continuing need for pharmacists to learn about dietary supplements and herbal products-and to educate pharmacists about newly introduced nonprescription products, devices, and diagnostic products.

Recently published clinical and pharmaceutical industry literature.

In a historical precedent, a third party insurer rather than a pharmaceutical company is attempting to force the switching of several prescription nonsedating antihistamines to OTC status. In addition, several developments related to the manufacture and use of dietary supplements have created concern for consumers and the pharmacists who advise them. It is critical for pharmacists to become knowledgeable about dietary supplements so they can appropriately counsel patients on the benefits and risks associated with supplement selection and use. In addition, numerous nonprescription products, including home diagnostic products and accessories, will continue to become available on the U.S. market. It is important that pharmacists become as knowledgeable as possible about these and be capable of educating the consuming public about their appropriate use.

Patients will continue to place an increasing emphasis on self-care. To assist them, pharmacists must remain up-to-date on trends and have a balanced understanding of new nonprescription products and dietary supplements. The new nonprescription medications and diagnostic products discussed in this review article represent valuable additions to the growing array of self-care products.